Congratulations to Dr. Michael Teitell (Faculty member in the Cell & Developmental Biology, Immunity, Microbes & Molecular Pathogenesis, & Molecular Pharmacology Home Areas) for his appointment as Director of the UCLA Jonsson Comprehensive Cancer Center. 

The Jonsson Comprehensive Cancer Center (JCCC) has over 500 physician and scientist members and provides the latest in experimental cancer treatments.  Several targeted cancer therapies have been developed based on basic science done in UCLA laboratories and clinical research with UCLA patients.  Research Programs within the JCCC include Cancer and Stem Cell Biology, Cancer Molecular Imaging, Cancer Nanotechnology, Gene Regulation, Healthy and At-Risk Populations, Patients and Survivors, Signal Transduction and Therapeutics, and Tumor Immunology.  Students within the Graduate Programs in Bioscience collaborate with and work in the labs of members within the 8 research areas of the JCCC. 

Dr. Teitell received concurrent bachelor’s and master’s degrees from the UCLA College Honors Program, and went on to earn his MD/PhD at UCLA, where he studied chemistry and biochemistry. He completed his postdoctoral training in anatomic pathology at Brigham and Women’s Hospital and Harvard Medical School, and at UC San Francisco as a resident in clinical pathology.

Teitell currently serves as co-director of the UCLA Tumor Immunology Training Program, co-director of the Broad Stem Cell Research Center Bioengineering Core, an associate director of the UCLA-Caltech Medical Scientist Training Program, and the NCAA faculty athletics representative for intercollegiate athletics at UCLA. Prior to being named director, he served as the cancer center’s director of basic and translational research.

Read the UCLA Newsroom story here.  Article also featured on myscience.org.